| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |